Latent Tuberculosis Infection

Latent Tuberculosis Screening

Information

References

¹	Latent tuberculosis infection: A guide for primary health care providers. Atlanta, GA: Centers for Disease Control and Prevention; 2013 [cited 2015 Apr 1].
²	Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection. MMWR Morb Mortal Wkly Rep. 2011; 60(48):1650-1653.
³	Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K. Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm Rep. 2010; 59(RR-5):1-25.
⁴	Core curriculum on Tuberculosis: what the clinician should know. Atlanta, GA: Centers for Disease Control and Prevention; 2013 [updated 2013 Jul 9; cited 2015 Apr 9].

Pathway does not replace clinical judgment and should be modified as needed for individual patients. Page last revised 12/3/2014 .
Please send comments to: piercerp@health.missouri.edu

© Curators of the University of Missouri. All rights reserved. DMCA and other copyright information. An equal opportunity/affirmative action institution.
Published by the Department of Family & Community Medicine , Columbia, MO 65211